89 related articles for article (PubMed ID: 25069535)
1. DPP4 inhibitors increase differentially the expression of surfactant proteins in Fischer 344 rats.
Schmiedl A; Grützner D; Hoffmann T; von Hörsten S; Stephan M
Acta Physiol (Oxf); 2014 Nov; 212(3):248-61. PubMed ID: 25069535
[TBL] [Abstract][Full Text] [Related]
2. Differential severity of LPS-induced lung injury in CD26/DPP4 positive and deficient F344 rats.
Zientara A; Stephan M; von Hörsten S; Schmiedl A
Histol Histopathol; 2019 Oct; 34(10):1151-1171. PubMed ID: 30977110
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.
Chua S; Lee FY; Tsai TH; Sheu JJ; Leu S; Sun CK; Chen YL; Chang HW; Chai HT; Liu CF; Lu HI; Yip HK
J Transl Med; 2014 Dec; 12():357. PubMed ID: 25496837
[TBL] [Abstract][Full Text] [Related]
4. Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases.
Stöckel-Maschek A; Mrestani-Klaus C; Stiebitz B; Demuth H; Neubert K
Biochim Biophys Acta; 2000 Jun; 1479(1-2):15-31. PubMed ID: 11004527
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Yazbeck R; Howarth GS; Abbott CA
Trends Pharmacol Sci; 2009 Nov; 30(11):600-7. PubMed ID: 19837468
[TBL] [Abstract][Full Text] [Related]
6. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
[TBL] [Abstract][Full Text] [Related]
7. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase expression during experimental colitis in mice.
Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
[TBL] [Abstract][Full Text] [Related]
10. Effects of dipeptidyl peptidase-4 inhibition in an animal model of experimental asthma: a matter of dose, route, and time.
Stephan M; Suhling H; Schade J; Wittlake M; Tasic T; Klemann C; Pabst R; Jurawitz MC; Raber KA; Hoymann HG; Braun A; Glaab T; Hoffmann T; Schmiedl A; von Hörsten S
Physiol Rep; 2013 Oct; 1(5):e00095. PubMed ID: 24303167
[TBL] [Abstract][Full Text] [Related]
11. In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma.
Jost MM; Lamerz J; Tammen H; Menzel C; De Meester I; Lambeir AM; Augustyns K; Scharpé S; Zucht HD; Rose H; Jürgens M; Schulz-Knappe P; Budde P
Biochem Pharmacol; 2009 Jan; 77(2):228-37. PubMed ID: 18940185
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.
Bjelke JR; Christensen J; Nielsen PF; Branner S; Kanstrup AB; Wagtmann N; Rasmussen HB
Biochem J; 2006 Jun; 396(2):391-9. PubMed ID: 16475979
[TBL] [Abstract][Full Text] [Related]
13. Postnatal morphological lung development of wild type and CD26/DPP4 deficient rat pups in dependency of LPS exposure.
Wagener I; Jungen M; von Hörsten S; Stephan M; Schmiedl A
Ann Anat; 2020 May; 229():151423. PubMed ID: 31654734
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
[TBL] [Abstract][Full Text] [Related]
15. Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model.
Neuhaus M; Munder A; Schipke J; Schmiedl A
Inflamm Res; 2019 Jul; 68(7):529-544. PubMed ID: 31089745
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
[TBL] [Abstract][Full Text] [Related]
17. Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory T cells and expression of pulmonary surfactant proteins.
Schmiedl A; Krainski J; Schwichtenhövel F; Schade J; Klemann C; Raber KA; Zscheppang K; Beekmann T; Acevedo C; Glaab T; Wedekind D; Pabst R; von Hörsten S; Stephan M
Clin Exp Allergy; 2010 Dec; 40(12):1794-808. PubMed ID: 20560982
[TBL] [Abstract][Full Text] [Related]
18. Maternal deprivation decelerates postnatal morphological lung development of F344 rats.
Hupa KL; Schmiedl A; Pabst R; Von Hörsten S; Stephan M
Anat Rec (Hoboken); 2014 Feb; 297(2):317-26. PubMed ID: 24357522
[TBL] [Abstract][Full Text] [Related]
19. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
[TBL] [Abstract][Full Text] [Related]
20. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
